i2E Managementi2E Managementi2E Managementi2E Management
  • About
  • Portfolio
  • Team
  • Funds
  • Investor Login

BioLytx

    Home library BioLytx
    NextPrevious

    BioLytx

    December 24, 2015
    0

    Biolytx Pharmaceuticals Corp. is based on technology developed by Anne Pereira and the OU Health Sciences Center. Its core technology is development of a novel antibiotic peptide for use in treatment of serious hospital-acquired infections, including those resistant to current antibiotics.

    Related Projects:

    Alkami Technology

    View more

    Alkami Technology

    Alkami Technology

    Alkami Technology
    2015-12-29

    Benefit Informatics, Inc.

    View more

    Benefit Informatics, Inc.

    Benefit Informatics, Inc.

    Benefit Informatics, Inc.
    2015-12-25

    BioLytx

    View more

    BioLytx

    BioLytx

    BioLytx
    2015-12-24

    Crescendo Bioscience

    View more

    Crescendo Bioscience

    Crescendo Bioscience

    Crescendo Bioscience
    2015-12-17

    Docvia

    View more

    Docvia

    Docvia
    2015-12-12

    Exaptive

    View more

    Exaptive

    Exaptive

    Exaptive
    2015-12-04

    Expert TA

    View more

    Expert TA

    Expert TA

    Expert TA
    2015-12-02

    Hyalose LLC

    View more

    Hyalose LLC

    Hyalose LLC

    Hyalose LLC
    2015-11-21

    • Disclaimer & Disclosure

    Oklahoma City Location

    840 Research Parkway, Suite 250
    OKC, OK 73104
    PHONE 405/235-2305

    Click HERE for directions.

    Tulsa Location

    618 E. Third Street, Suite 1
    Tulsa, OK 74120
    PHONE 918/582-5592

    Click HERE for directions.

    • Disclaimer & Disclosure
    Copyright 2021 i2E, Inc. | All Rights Reserved
    • About
    • Portfolio
    • Team
    • Funds
    i2E Management